3 unknown, 2 completed, 1 not yet recruiting, 1 recruiting. 4 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Unknown 2, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Asymptomatic Hyperuricemia: new trials by email Literature Review of Asymptomatic Hyperuricemia trials Research Report on Asymptomatic Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Effects and Mechanisms of Probiotic Supplementation in Ameliorating Uric Acid Metabolism in Asymptomatic Hyperuricemic Individuals Probiotic, Placebo - Asymptomatic Hyperuricemia | Not applicable | Not yet recruiting | Sun Yat-sen University | 68 | 2026-07-01 | 2026-06-16 |
| Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA) Manual acupuncture, Sham acupuncture - Asymptomatic Hyperuricemia | Not applicable | Recruiting | Shenghao Tu | 260 | 2025-03-25 | 2025-03-30 |
| Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout Gout Flare, Intercritical Gout | Unknown | Ai Peng | 600 | 2022-09-15 | 2024-05-08 | |
| Efficacy Study of Acupuncture on Asymptomatic Hyperuricemia verum acupuncture, health education, sham acupuncture - Asymptomatic Hyperuricemia | Not applicable | Unknown | Lingling Yu (103250) | 180 | 2022-07-13 | 2024-03-12 |
| A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia SIBP-R002, Dexamethasone or Methyl prednisolone, Diphenhydramine - Asymptomatic Hyperuricemia | Phase 1 | Completed | Shanghai Institute Of Biological Products | 45 | 2022-04-11 | 2023-12-27 |
| The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout Sodium Bicarbonate - Asymptomatic Hyperuricemia, Gout | Not applicable | Unknown | Shanghai Zhongshan Hospital | 104 | 2017-11-01 | 2017-10-11 |
| A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA Verinurad, Febuxostat, Dapagliflozin - Asymptomatic Hyperuricemia | Phase 2 | Completed | AstraZeneca | 36 | 2017-10-25 | 2019-08-28 |
Gout (2) · Hyperuricemia (2)
Arthritis (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Crystal Arthropathies (2) · Genetic Diseases, Inborn (2) · Joint Diseases (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Purine-Pyrimidine Metabolism, Inborn Errors (2) · Rheumatic Diseases (2)
Dexamethasone (1) · Diphenhydramine (1) · Febuxostat (1) · Probiotics (1) · Sodium Bicarbonate (1) · dapagliflozin (1) · verinurad (1)
Ai Peng (1) · AstraZeneca (1) · Lingling Yu (103250) (1) · Shanghai Institute Of Biological Products (1) · Shanghai Zhongshan Hospital (1) · Shenghao Tu (1) · Sun Yat-sen University (1)
China (5) · United States (1)
Ai Peng, MD, PhD (1) · Huan Zhou (1) · Shenghao Tu, Ph.D (1) · Shenghao Tu, PhD (1)